Douglas John Karas - Net Worth and Insider Trading
Douglas John Karas Net Worth
The estimated net worth of Douglas John Karas is at least $4,463 dollars as of 2024-11-13. Douglas John Karas is the Director of Nascent Biotech Inc and owns about 60,000 shares of Nascent Biotech Inc (NBIO) stock worth over $4,463. Details can be seen in Douglas John Karas's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas John Karas has not made any transactions after 2015-04-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Douglas John Karas
Douglas John Karas Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas John Karas owns 1 companies in total, including Nascent Biotech Inc (NBIO) .
Click here to see the complete history of Douglas John Karas’s form 4 insider trades.
Insider Ownership Summary of Douglas John Karas
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBIO | Nascent Biotech Inc | 2015-04-03 | director |
Douglas John Karas Latest Holdings Summary
Douglas John Karas currently owns a total of 1 stock. Douglas John Karas owns 60,000 shares of Nascent Biotech Inc (NBIO) as of April 3, 2015, with a value of $4,463.
Latest Holdings of Douglas John Karas
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBIO | Nascent Biotech Inc | 2015-04-03 | 60,000 | 0.07 | 4,463 |
Holding Weightings of Douglas John Karas
Douglas John Karas Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas John Karas has made a total of 0 transactions in Nascent Biotech Inc (NBIO) over the past 5 years. The most-recent trade in Nascent Biotech Inc is the acquisition of 10,000 shares on April 3, 2015, which cost Douglas John Karas around $10,000.
Insider Trading History of Douglas John Karas
- 1
Douglas John Karas Trading Performance
GuruFocus tracks the stock performance after each of Douglas John Karas's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas John Karas is 38.1%. GuruFocus also compares Douglas John Karas's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas John Karas within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas John Karas's insider trading performs compared to the benchmark.
Performance of Douglas John Karas
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 26.67 | | | | | |
| Relative Return to S&P 500(%) | 24.67 | | | | | |
Douglas John Karas Ownership Network
Ownership Network List of Douglas John Karas
Ownership Network Relation of Douglas John Karas
Douglas John Karas Owned Company Details
What does Nascent Biotech Inc do?
Who are the key executives at Nascent Biotech Inc?
Douglas John Karas is the director of Nascent Biotech Inc. Other key executives at Nascent Biotech Inc include director & CFO Lowell Thomas Holden , director & President Sean Carrick , and director & Senior VP Business Development Brandon Price .
Nascent Biotech Inc (NBIO) Insider Trades Summary
Over the past 18 months, Douglas John Karas made no insider transaction in Nascent Biotech Inc (NBIO). Other recent insider transactions involving Nascent Biotech Inc (NBIO) include a net purchase of 130,000 shares made by Lowell Thomas Holden ,
In summary, during the past 3 months, insiders sold 0 shares of Nascent Biotech Inc (NBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nascent Biotech Inc (NBIO) were sold and 130,000 shares were bought by its insiders, resulting in a net purchase of 130,000 shares.
Nascent Biotech Inc (NBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nascent Biotech Inc Insider Transactions
Douglas John Karas Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas John Karas. You might contact Douglas John Karas via mailing address: 631 Us Hwy 1, Suite 407, North Palm Beach Fl 33408.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
